Other Receivables

Current Assets

UnitedHealth Group Other Receivables increased by 14.6% to $32.76B in Q3 2025 compared to the prior quarter. Year-over-year, this metric grew by 19.3%, from $27.46B to $32.76B. Over 4 years (FY 2020 to FY 2024), Other Receivables shows an upward trend with a 20.1% CAGR.

Analysis

StatementBalance Sheet Statement
SectionCurrent Assets
CategoryLiquidity
SignalContext dependent
VolatilityModerate
First reportedQ4 2014
Last reportedQ3 2025

How to read this metric

Significant fluctuations may indicate one-time events or changes in non-operating business activities.

Detailed definition

This category includes miscellaneous claims for cash that are not derived from standard trade sales of pharmaceutical pr...

Peer comparison

Varies widely based on the complexity of a company's tax structure and collaborative R&D agreements.

Metric ID: other_receivables

Historical Data

18 periods
 Q2 '21Q3 '21Q4 '21Q1 '22Q2 '22Q3 '22Q4 '22Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25
Value$12.63B$14.08B$13.87B$11.99B$12.44B$13.68B$12.77B$14.70B$16.13B$17.75B$17.69B$19.28B$26.76B$27.46B$26.09B$26.02B$28.58B$32.76B
QoQ Change+11.5%-1.5%-13.5%+3.7%+10.0%-6.7%+15.1%+9.8%+10.0%-0.3%+9.0%+38.8%+2.6%-5.0%-0.3%+9.8%+14.6%
YoY Change-1.5%-2.8%-7.9%+22.5%+29.7%+29.7%+38.6%+31.2%+65.9%+54.7%+47.4%+34.9%+6.8%+19.3%
Range$11.99B$32.76B
CAGR+25.1%
Avg YoY Growth+26.3%
Median YoY Growth+29.7%
Current Streak2 quarters growth

Frequently Asked Questions

What is UnitedHealth Group's other receivables?
UnitedHealth Group (UNH) reported other receivables of $32.76B in Q3 2025.
How has UnitedHealth Group's other receivables changed year-over-year?
UnitedHealth Group's other receivables increased by 19.3% year-over-year, from $27.46B to $32.76B.
What is the long-term trend for UnitedHealth Group's other receivables?
Over 4 years (2020 to 2024), UnitedHealth Group's other receivables has grown at a 20.1% compound annual growth rate (CAGR), from $12.53B to $26.09B.
What does other receivables mean?
Money owed to the company from sources other than regular customer sales.

Cookie Preferences

We use cookies for analytics. See our Privacy and Cookie Policy.